Carregant...
Chelation for autism spectrum disorder (ASD)
BACKGROUND: It has been suggested that the severity of autism spectrum disorder (ASD) symptoms is positively correlated with the level of circulating or stored toxic metals, and that excretion of these heavy metals, brought about by the use of pharmaceutical chelating agents, results in improved sym...
Guardat en:
| Publicat a: | Cochrane Database Syst Rev |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2015
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6457964/ https://ncbi.nlm.nih.gov/pubmed/26114777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010766.pub2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|